Medication Therapy Management (MTM) is a free service for Medicare Part D patients taking multiple chronic disease medications. It includes a pharmacist-led review to reduce risks, cut costs, and improve adherence - with no extra charges.
Pancreatic cancer is often detected too late, but early symptoms like unexplained weight loss, new-onset diabetes, and jaundice can signal trouble. Learn the warning signs and latest treatment advances that are improving survival.
Learn how to talk to your doctor about generic vs. brand-name medications, why generics are just as effective, when to ask for brand-name drugs, and how to save money without risking your health.
Floaters and flashes are common with age but can signal serious eye problems. Learn what's normal, when to worry, and why quick action can save your vision.
Post-market surveillance catches dangerous side effects that clinical trials miss. Learn how real-world data from patients and doctors helps uncover hidden risks in drugs and medical devices after approval.
Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs under FDA regulations. Learn how bioequivalence testing, manufacturing controls, and strict approval processes ensure generics work just as well.
Medical societies have conflicting positions on generic drug substitution. While most support generics for cost savings, neurologists and others warn against switching NTI drugs like anticonvulsants due to safety risks. What providers really think - and what patients should know.
Chronic bronchitis and emphysema are the two main forms of COPD. They have different causes, symptoms, and treatments. Understanding which one you have-or if you have both-is key to breathing better and avoiding hospital visits.
Psychiatric medication combinations can be life-changing, but switching to generic versions can trigger treatment failure, relapse, or hospitalization. Learn which drugs are safest to substitute-and which ones demand brand consistency.
Most clinicians don't know the real cost of the drugs they prescribe. This article explores why drug pricing knowledge is lacking, how it affects patient care, and what's being done to fix it-with real data and actionable insights.
